Following publication of KEYNOTE-689 Phase 3 results confirming the role of perioperative checkpoint inhibition in head and neck cancer, GeoVax announced plans for a Phase 2 trial (AdPNP-203) ...
Bragg Gaming Group ("Bragg" or the "Company"), a leading content and technology provider to the online gaming industry, today announced its financial results for the third quarter of 2025. Third ...